These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4075296)

  • 1. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the relationship between therapeutic schedule and antitumor effect of etoposide and cytosine arabinoside in murine L1210 leukemia].
    Ooi K; Ohkubo T; Kawasaki H; Sakurai M
    Yakugaku Zasshi; 1989 Nov; 109(11):865-8. PubMed ID: 2614669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
    Roberts D; Peck C; Hilliard S; Karas JG
    Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.
    Wampler GL; Carter WH; Campbell ED; Goldman ID
    Cancer Treat Rep; 1987 Jun; 71(6):581-91. PubMed ID: 3581096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL; Carter WH; Campbell ED
    Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 8. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
    Chello PL; Sirotnak FM; Dorick DM; Moccio DM
    Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanism of synergistic interaction between etoposide and cytarabine].
    Ooi K
    Yakugaku Zasshi; 2002 Jul; 122(7):471-80. PubMed ID: 12136643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
    Dombernowsky P; Nissen NI
    Eur J Cancer (1965); 1976 Mar; 12(3):181-8. PubMed ID: 939236
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal methotrexate in the treatment of murine L1210 leukemia.
    Woo SY; Dilliplane P; Rahman A; Sinks LF
    Cancer Drug Deliv; 1983; 1(1):59-62. PubMed ID: 6544118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential MTX and 5-FU: advance or myth?
    Coates A
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):131-3. PubMed ID: 3516706
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
    Piper AA; Nott SE; Mackinnon WB; Tattersall MH
    Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.